Kapcare SA
Ouverture de faillite 6.8 FTEKapcare reported total assets of €2.82m at the end of the 2024 financial year (annual accounts filed with the NBB on 22 Jul 2025), with 6.8 full-time equivalents.
The score of Kapcare shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2021 → 2024: Equity -86 % Total assets -14 % Headcount (avg FTE) -17 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Kapcare's annual accounts
Filed annual accounts
- Year ended 31 Dec 2024filed on 22 Jul 2025
- Year ended 31 Dec 2023filed on 16 Sep 2024
- Year ended 31 Dec 2022filed on 28 Aug 2023
- Year ended 31 Dec 2021filed on 29 Aug 2022
- Year ended 31 Dec 2020filed on 30 Aug 2021
Kapcare's financial analysis
- Solvency13.6%sector median: 33.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Kapcare
Kapcare's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0680.977.810
- VAT number
- BE0680977810
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SA
- Incorporated
- 13 Sep 2017
- Registered office
- 1160 Auderghem
- Size
- Micro · 6.8 FTE
- Latest accounts
- 2024 · filed on 22 Jul 2025
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Kapcare (SA) has been based in Auderghem since 2017, active in: wholesale of pharmaceutical and medical goods. For 2024, it reports a net loss of €1.42m and equity of 384,155 €; its revenue is not published. With 6.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 13.6%, below the median of its sector (33.7%).
Companies similar to Kapcare
Companies in the same business, of comparable size and area, outside its group.
- GHX Europe Wholesale of pharmaceutical and medical goods Brussels · balance sheet €2.81m
- Menarini Stemline Benelux NV/SA Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €2.57m
- LPG Benelux Wholesale of pharmaceutical and medical goods Drogenbos · balance sheet €3.55m
- Feton Wholesale of pharmaceutical and medical goods Uccle · balance sheet 806,088 €
- Viatris GX Wholesale of pharmaceutical and medical goods Hoeilaart · balance sheet €31.1m
- Servicov Wholesale of pharmaceutical and medical goods Ghent · balance sheet €3.54m
- Euromedix Point OF Care Wholesale of pharmaceutical and medical goods Leuven · balance sheet €3.24m
- Dubavo Wholesale of pharmaceutical and medical goods Lo-Reninge · balance sheet €3.97m
Frequently asked questions about Kapcare
What is the revenue of Kapcare?
Kapcare files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of Kapcare?
In Belgium, the VAT number is the company number prefixed with BE: BE0680977810 for Kapcare, if the company is VAT-registered. Its company number (CBE) is 0680.977.810.
Where is the registered office of Kapcare?
According to the CBE register, the registered office of Kapcare is in 1160 Auderghem.
What is the equity of Kapcare?
At the close of the 2024 financial year, the equity of Kapcare amounts to 384,155 €, a solvency of 13.6% of total assets.
How many people work at Kapcare?
6.8 full-time equivalents on average according to the 2024 social balance sheet.
Who manages Kapcare?
The register lists 14 active mandates at Kapcare. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Kapcare
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →